American Society of Clinical Oncology

SHERPA: White

People

  1. Arcila
    Arcila
  2. Kris
    Kris
  3. Ladanyi
    Ladanyi
  4. Miller
    Miller
  5. Riely
    Riely
  6. Drilon
    Drilon
  7. Janjigian
    Janjigian
  8. Paik
    Paik

Groups

  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Human Oncology and Pathogenesis Program (5)
  4. Solid Tumor Oncology Division (5)
  5. Thoracic Oncology (5)
  6. Tow Center for Developmental Oncology (TCDO) (5)
  7. Gastrointestinal Oncology Service (1)
Search Within
  1. "Vincent Miller"
  2. "Maria Arcila"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Human Oncology and Pathogenesis Program (5)
  4. Solid Tumor Oncology Division (5)
  5. Thoracic Oncology (5)
  6. Tow Center for Developmental Oncology (TCDO) (5)

More Groups

People
  1. Marc Ladanyi (5)
  2. Maria Arcila (5)
  3. Mark Kris (5)
  4. Vincent Miller (5)
  5. Gregory Riely (3)
  6. Geoffrey Oxnard (2)

More People

Years
  1. 2014 (1)
  2. 2011 (2)
  3. 2010 (1)
  4. 2009 (1)
Publications
  1. Journal of Clinical Oncology (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in "pan-negative" lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history
    Meeting Abstract

    Drilon, A. E.; Wang, L.; Arcila, M. E.; Cho, E. J.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Maintained sensitivity to EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutant lung cancers that recur after adjuvant TKI
    Meeting Abstract

    Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; Miller, V. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations
    Journal Article

    Paik, P. K.; Arcila, M. E.; Fara, M.; Sima, C. S.; Miller, V. A.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical course of patients (pts) with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKI)
    Meeting Abstract

    Oxnard, G. R.; Riely, G. J.; Arcila, M. H.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Rebiopsy of patients (pts) with acquired resistance to epidermal growth factor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Arcila, M. E.; Riely, G. J.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Pao, W.; Miller, V. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save